Disclosures for "Diffuse Cerebral Microhemorrhages Following Intrathecal Nivolumab: A Case Report of a Rare Immune Checkpoint Inhibitor Neurotoxicity"
-
Dr. Asedi has nothing to disclose.
-
Mr. Hijazi has nothing to disclose.
-
Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier Pharmaceuticals.